LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: eRapid is a low-cost, affinity-based electrochemical sensing platform (Photo courtesy of StataDX)

Electrochemical Sensor Platform to Enable New Diagnostic Tests in Near-Patient Settings

A novel electrochemical sensor platform will pave the way for the development and commercialization of cost-effective, highly sensitive and specific point-of-care diagnostics for neurological, cardiovascular, and renal diseases. More...
28 Jun 2022
Image: The INVIEW Oncopanel All-in-one is the most comprehensive gene panel available for optimized detection of tumor-specific genomic alterations (Photo courtesy of Eurofins Genomics)

Molecular Tumor Profiling Benefits Pediatric Cancer Patients

Molecular tumor profiling, a highly technical laboratory genetic test can identify the specific genetic alterations implicated in cancer growth and thus identify treatments that target these specific mutations. More...
27 Jun 2022
DIASOURCE (A Biovendor Company)
Image: A new method reliably detects protein changes in blood that are typical of Parkinson`s disease (Photo courtesy of Pexels)

First-Ever Blood Test Detects Parkinson’s Disease

To date, there have been neither blood parameters nor imaging examinations to produce a definite diagnosis of Parkinson's disease, let alone early recognition. Now, researchers have developed a method that reliably detects protein changes in blood that are typical of Parkinson's disease. More...
24 Jun 2022
Image: Automated liquid biopsy test quickly IDs cancer DNA in patients with metastatic breast cancer (Photo courtesy of Johns Hopkins)

Automated Liquid Biopsy Test Detects Advanced Breast Cancer in Five Hours

A novel, automated liquid biopsy test in development can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within five hours. More...
24 Jun 2022
Image: Stages of progression of non-alcoholic fatty liver disease (Photo courtesy of Wikimedia Commons)

Blood Test Predicts Likelihood that Nonalcoholic Fatty Liver Disease Will Progress to Liver Cancer

A bioinformatics approach was used to transform a 133-gene panel, which could predict the likelihood of a patient with nonalcoholic fatty liver disease (NAFLD) progressing to hepatocellular carcinoma (HCC), into an easily performed four-protein blood test. More...
23 Jun 2022
Image: Professor Colin Raston and Dr Xuan Luo with a VFD (Photo courtesy of Flinders University)

High-Tech Method for Protein Biomarker Assay Testing to Revolutionize POC Diagnosis

A speedy high-tech method of inexpensive, accurate and high-throughput protein biomarker assay testing is being touted as a much-needed development in point-of-care (PoC) testing. More...
23 Jun 2022
Image: PromarkerD blood test assesses risk of diabetic kidney disease in patients with type 2 diabetes (Photo courtesy of Proteomics)

Blood Test Detects Unique ‘Fingerprint’ of Early Onset of Diabetic Kidney Disease

A blood test that assess the risk of diabetic kidney disease (DKD) in patients with type 2 diabetes has also demonstrated the potential to predict late-stage, as well as early-stage, renal decline. More...
23 Jun 2022
Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Candida Glabrata Test
ELIchrom Glabrata


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
PURITAN MEDICAL